Matthew Rabinowitz
Founder en NATERA, INC. .
Fortuna: 177 M $ al 31/03/2024
Perfil
Matthew Rabinowitz es un empresario que fundó Natera, Inc, Rosum Corp. y Panop.com, Inc. En la actualidad, ocupa el cargo de Presidente Ejecutivo de Natera, Inc. También forma parte del consejo de GenEdit, Inc. y de la Acmg Foundation For Genetic & Genomic Medicine. En el pasado, Matthew Rabinowitz fue Director de Tecnología de Rosum Corp. y Científico Jefe de Panop.com, Inc. El Dr. Rabinowitz se graduó, se licenció y se doctoró en la Universidad de Stanford.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
NATERA, INC.
1.60% | 23/04/2024 | 1 934 237 ( 1.60% ) | 177 M $ | 31/03/2024 |
Cargos activos de Matthew Rabinowitz
Empresas | Cargo | Inicio |
---|---|---|
NATERA, INC. | Founder | 01/11/2003 |
GenEdit, Inc.
GenEdit, Inc. Pharmaceuticals: MajorHealth Technology GenEdit, Inc. develops gene therapies and gene editing-based therapeutics. Its proprietary nanoparticles applies for the development of CRISPR-based therapeutics and gene therapy products for a range of genetic diseases. The company was founded by Kunwoo Lee, Niren Murthy, and Hyo Min Park in 2016 and is headquartered in Berkeley, CA. | Director/Board Member | - |
Acmg Foundation For Genetic & Genomic Medicine | Director/Board Member | - |
MyOme, Inc.
MyOme, Inc. Medical SpecialtiesHealth Technology MyOme, Inc. is a clinical whole genome analysis platform company that helps families understand their risk for inherited diseases. Certified under the Clinical Laboratory Improvement Amendments (CLIA), MyOme is based in San Carlos, CA. The company is a leader in polygenic modeling and leverage the power of the whole genome for a lifetime of actionable insights. In 2017, a group of geneticists, clinicians, biologists, engineers, parents, daughters, and sons formed MyOme believing that everyone can benefit from their services. MyOme maintains internet-accessible web sites, interactive user interfaces, mobile applications, and application programming interfaces for healthcare providers to complete the test requisition form (TRF) on their health system's interface. The company's proactive health report includes 78 genes identified as medically actionable by the American College of Medical Genetics and Genomics, providing a more complete picture of disease risk through clinical grade whole genome sequencing (up to 30x) and analysis. The company was founded by Matthew Rabinowitz, Kate Im, Akash Kumar, and Oren Schaedel. The CEO is Premal S. Shah. | Founder | - |
Antiguos cargos conocidos de Matthew Rabinowitz.
Empresas | Cargo | Fin |
---|---|---|
Rosum Corp.
Rosum Corp. Electronics/Appliance StoresRetail Trade Rosum is the leader in the use of broadcast TV signals to power location and timing solutions. Rosum technology turns TV tuners into location devices, and Rosum is the first to combine TV and GPS signals for truly robust hybrid positioning and timing in all types of environments. Rosum's founding team includes the original architects of the GPS constellation. Rosum partners include Siano Mobile Silicon, TruePosition, and ST-Ericsson | Chief Executive Officer | 01/01/2003 |
Panop.com, Inc.
Panop.com, Inc. Internet Software/ServicesTechnology Services Part of Verint Systems, Inc., Panop.com, Inc. develops real-time interaction technology across Web, WAP devices, e-mail, and call center interaction points. The private company is based in Palo Alto, CA. The company was founded by Kim H. Stanley, Matthew Rabinowitz. Panop.com was acquired by Broadbase Software, Inc. on September 21, 2000 for $47.71 million. | Founder | 01/01/2000 |
Formación de Matthew Rabinowitz.
Stanford University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
NATERA, INC. | Health Technology |
Empresas privadas | 5 |
---|---|
Rosum Corp.
Rosum Corp. Electronics/Appliance StoresRetail Trade Rosum is the leader in the use of broadcast TV signals to power location and timing solutions. Rosum technology turns TV tuners into location devices, and Rosum is the first to combine TV and GPS signals for truly robust hybrid positioning and timing in all types of environments. Rosum's founding team includes the original architects of the GPS constellation. Rosum partners include Siano Mobile Silicon, TruePosition, and ST-Ericsson | Retail Trade |
Panop.com, Inc.
Panop.com, Inc. Internet Software/ServicesTechnology Services Part of Verint Systems, Inc., Panop.com, Inc. develops real-time interaction technology across Web, WAP devices, e-mail, and call center interaction points. The private company is based in Palo Alto, CA. The company was founded by Kim H. Stanley, Matthew Rabinowitz. Panop.com was acquired by Broadbase Software, Inc. on September 21, 2000 for $47.71 million. | Technology Services |
GenEdit, Inc.
GenEdit, Inc. Pharmaceuticals: MajorHealth Technology GenEdit, Inc. develops gene therapies and gene editing-based therapeutics. Its proprietary nanoparticles applies for the development of CRISPR-based therapeutics and gene therapy products for a range of genetic diseases. The company was founded by Kunwoo Lee, Niren Murthy, and Hyo Min Park in 2016 and is headquartered in Berkeley, CA. | Health Technology |
Acmg Foundation For Genetic & Genomic Medicine | Miscellaneous |
MyOme, Inc.
MyOme, Inc. Medical SpecialtiesHealth Technology MyOme, Inc. is a clinical whole genome analysis platform company that helps families understand their risk for inherited diseases. Certified under the Clinical Laboratory Improvement Amendments (CLIA), MyOme is based in San Carlos, CA. The company is a leader in polygenic modeling and leverage the power of the whole genome for a lifetime of actionable insights. In 2017, a group of geneticists, clinicians, biologists, engineers, parents, daughters, and sons formed MyOme believing that everyone can benefit from their services. MyOme maintains internet-accessible web sites, interactive user interfaces, mobile applications, and application programming interfaces for healthcare providers to complete the test requisition form (TRF) on their health system's interface. The company's proactive health report includes 78 genes identified as medically actionable by the American College of Medical Genetics and Genomics, providing a more complete picture of disease risk through clinical grade whole genome sequencing (up to 30x) and analysis. The company was founded by Matthew Rabinowitz, Kate Im, Akash Kumar, and Oren Schaedel. The CEO is Premal S. Shah. | Health Technology |
- Bolsa de valores
- Insiders
- Matthew Rabinowitz